Announcing Earth Day Plus (Apr 22 to May 3) – VC-Founder Matchup + Live Sessions. Learn More

Able Sciences

RNA-based Off the Shelf Immune Cells for Cell Therapies

Team

Thimmaiah Chendrimada

Co-Founder & CSO

Company details

Able Sciences, Inc. (Able) is deploying a leading-edge RNA technology platform to develop highly differentiated off-the-shelf, cost-effective cell therapies leading with NK cells to cure Solid Cancers and Autoimmune Disorders.

Get In Touch with Able Sciences

Please tell us a little bit about yourself and why you'd like to get connected. Able Sciences + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.